Q2
– Seed Funding from private investors
Q3
– Exclusive License from NIH on Photoimmunotherapy
Q4 2013 to Q1 2015
– Execution on preclinical/CMC to IND for RM-1929
Home > Timelines > 2013
Pipeline
Pipeline
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
© Rakuten Medical Inc. 2022, All rights reserved.